Barrx Medical, Inc.
Barrx Medical initiates study comparing two treatment options for Barrett esophagus
Published in Medical Imaging Law Weekly, April 18th, 2006
The AIM dysplasia trial will compare the effectiveness of the HALO360 System against the current standard of care for Barrett esophagus, which includes regular endoscopic biopsy surveillance and appropriate medical management of associated acid reflux disease (also called GERD). Barrett esophagus, often caused by chronic GERD, is a pre-cancerous change to the lining of the esophagus that affects approximately three million U.S. adults.
Barrett sufferers are at...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Law Weekly
More Articles from Medical Imaging Law Weekly
- Agenix
Agenix reports a reduction in operating costs - AngioDynamics, Inc.
AngioDynamics reports income is up 73% - Applied Imaging Corp.
Applied Imaging reports income of $0.06 per share in 2005 Q4 - Henan Provincial Research Institute of Tuberculosis, Zhengzhou
Antituberculosis drug resistance mutations screened by DHPLC - Albert-Ludwigs-Universitat Freiburg
Transesophageal echocardiography can be essential to clarify stroke etiology - Baskent University, Konya
Researchers report details of new studies and findings in the area of hypertension - More from this issue of Medical Imaging Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
